Delivery Order SPE2DB22D1106-SPE2DB25FEVT0
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,180.32 to AmerisourceBergen Drug Corp for Trokendi XR 50 mg capsules (30-count) on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price, non-set-aside delivery order was placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The product will be...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Trokendi XR 100 mg capsules (30-count units) under a firm fixed-price contract with a ceiling value of $4,392.42. This non-set-aside award represents a competitively awarded delivery order for pharmaceutical products supporting federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Trokendi XR 100 mg capsules (30-count units) with a ceiling value of $2,168.86. This is a firm fixed-price delivery order with no set-aside designation, performed competitively. The order is scheduled for completion by July 16, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Trokendi XR 25 mg capsules (30-count) valued at $1,476.35. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for completion by May 1, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Trokendi XR 100 mg capsules (30-count packages) with a ceiling value of $3,379.08. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 22, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will...
- The Defense Logistics Agency awarded a $2,308.25 delivery order to AmerisourceBergen Drug Corp on May 13, 2025, for the supply of Trokendi XR 100 mg capsules (30-count units). This firm fixed price delivery order, with an ultimate completion date of May 14, 2025, represents a single transaction under AmerisourceBergen's broader pharmaceutical supply arrangements with the federal government. The award was made through open competition with no set-aside designation, reflecting the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 29, 2025, for the supply of Trokendi XR 200 mg capsules (30-count units) with a ceiling value of $12,939.63. This is a firm fixed-price delivery order with no set-aside designation, indicating the award resulted from open competition. The contract is set to be completed by April 30, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,689.54 to AmerisourceBergen Drug Corp for the supply of Trokendi XR 100 mg capsules (30-count). This firm fixed-price, competitively awarded contract with no set-aside designation was executed on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Trokendi XR 50 mg capsules in a 30-count package, with a contract ceiling value of $1,348.85. The award, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, represents a firm fixed price delivery order with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Trokendi XR 100 mg capsules (30-count). The contract ceiling value is $1,304.52, with an ultimate completion date of May 13, 2025. This is a non-set-aside, competitively awarded delivery order that will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEVT0Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for the supply of Trokendi XR 100 mg capsules (30-count units) under a firm fixed-price contract valued at $1,915.56. This competitively awarded, non-set-aside delivery order is set for completion by July 1, 2025, with performance to be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The award represents a single delivery order line item supporting federal pharmaceutical procurement needs, likely for military or veteran healthcare systems managed through DLA's medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support on a global basis. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp regularly fulfills delivery orders for brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains. The company's extensive portfolio of federal awards demonstrates its capability to meet competitive federal procurement requirements and serve Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible prime vendor vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 6/30/25 |